Aristo Bio-Tech & Lifescience Q2 FY27 Share Price & Earnings Call Analysis

₹117.90+1.25% today
Market cap
₹80 Cr
P/E
11.18
ROE
17.63%
PEG
0.42
Price to sales
0.22
Debt to equity
0.80
52W high / low
₹144 / ₹74.3
Sales growth (5Y)
16.85%
EBITDA margin
4.41%
Net profit margin
1.97%
Promoter holding
73.42%
Sales (last year)
₹364 Cr

Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance

  1. 2
  2. Anya Polytech &Good growth
    1
  3. 3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Aristo Bio-Tech & Lifescience shareholding (Sep 2026)

Promoters

73.42%

unchanged QoQ

FIIs

—

— QoQ

DIIs

—

— QoQ

Public

26.58%

unchanged QoQ

Peers

Fertilizers & Agrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
1Anya Polytech &20–40%Up 2%+₹209 Cr25.0
2Insecticides India20–40%Up 0–2%₹1,591 Cr13.0
3Madhya Bharat Agro Products20–40%Flat₹9,124 Cr58.9
420–40%Flat₹7,714 Cr39.2
510–20%Flat₹53,862 Cr33.7
610–20%Flat₹15,672 Cr8.2

Financials of Aristo Bio-Tech

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Aristo Bio-Tech

Shareholding breakup across reporting periods.

Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Promoters +73.37%73.37%73.37%73.37%73.42%73.42%73.42%73.42%
Public +26.62%26.63%26.63%26.63%26.58%26.58%26.58%26.58%
No. of Shareholders660652742625512468453442

Financials of Aristo Bio-Tech

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Aristo Bio-Tech

Profit & Loss

Annual income statement trend

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +57159271202201167166218245318364
Sales growth+180%+70%-26%-0%-17%-1%+31%+13%+30%+14%
Expenses +56157263195197163160209236309348
Operating Profit137754598916
OPM %1.6%1.6%2.7%3.4%2.2%2.6%3.3%4.0%3.5%2.9%4.4%
Other Income +01100000000
Interest01223223224
Depreciation00011112233
Profit before tax136412255510
Tax %33%31%34%31%28%28%28%25%28%26%26%
Net Profit +02431114447
EPS in Rs0.803.707.485.672.022.162.145.235.735.9610.55
Dividend Payout %0%0%0%0%0%0%0%5%7%10%6%

Financials of Aristo Bio-Tech

Balance Sheet

Capital structure and asset base

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital11155557777
Reserves2476781023273137
Borrowings +510201420222522212235
Other Liabilities +2072606556463747738176
Total Liabilities27878991888177100127141155
Fixed Assets +22888121416222424
CWIP00013001000
Investments00000000000
Other Assets +2585818177696383106117131
Total Assets27878991888177100127141155

Financials of Aristo Bio-Tech

Cash Flows

Operating, investing and financing cash movement

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-418127-38109
Cash from Investing Activity +0-5-2-2-2-3-4-7-5-3
Cash from Financing Activity +44-61-1-38-2-4-4
Net Cash Flow0-0-00-001-102
Free Cash Flow-406-104-7156
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit-123%38%138%40%60%134%-17%106%123%71%

Financials of Aristo Bio-Tech

Ratios

Working capital efficiency and return ratios

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days92121657788727375866555
Inventory Days6667426547786057655970
Days Payable14217785124749387851129778
Cash Conversion Cycle1611231861564648382647
Working Capital Days314141520282536312224
ROCE %31%34%24%14%11%12%16%13%13%20%

Aristo Bio-Tech & Lifescience: frequently asked questions

What is Aristo Bio-Tech & Lifescience share price today?

Aristo Bio-Tech & Lifescience last traded at ₹117.9, with a market capitalisation of ₹80 Cr and a P/E ratio of 11.2.

What is the promoter holding in Aristo Bio-Tech & Lifescience?

Promoters held 73.42% of Aristo Bio-Tech & Lifescience in Sep 2026 (unchanged versus Mar 2026).

What is Aristo Bio-Tech & Lifescience's ROE and ROCE?

Aristo Bio-Tech & Lifescience's return on equity is 17.6% and its return on capital employed is 19.6%.

Does Aristo Bio-Tech & Lifescience pay a dividend?

Yes. Aristo Bio-Tech & Lifescience's dividend yield is 0.51% at the current price. The full payout history is on the Aristo Bio-Tech & Lifescience dividends page.

Which sector does Aristo Bio-Tech & Lifescience belong to?

Aristo Bio-Tech & Lifescience is in the Fertilizers & Agrochemicals sector. Its peer comparison and sector ranking are on this page.

What did Aristo Bio-Tech & Lifescience's management say on the latest earnings call?

Arthneeti's analysis of the Q2 FY27 earnings call covers revenue, margins, capex and fundraising guidance from Aristo Bio-Tech & Lifescience's management.

How does Arthneeti AI analyse Aristo Bio-Tech & Lifescience?

Arthneeti reads Aristo Bio-Tech & Lifescience's earnings call transcripts and filings and scores revenue growth, margins, capex and fundraising, then ranks the company against its sector.

What Aristo Bio-Tech's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Madhya Bharat Agro Products (Q2 FY27)

    Q2 FY27 Revenue: ₹715 crore, up 59% YoY (Page 12, Chairman’s Quote) . Key investor presentation takeaways from Madhya Bharat Agro Products Ltd's Q2 FY27 investo

  • Dhansa Labs (Q2 FY27)

    1,864 crores during H1 FY27. Key results statement takeaways from Dhansa Labs Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Krishana Phoschem (Q2 FY27)

    Year-on-year revenue growth: Rs 70,254.28 Lakhs vs Rs 60,786.41 Lakhs (~15.6% increase) . Key results statement takeaways from Krishana Phoschem Ltd's Q2 FY27 e

  • Balaji Phosphates (Q2 FY27)

    Year-on-year growth for the half year (Standalone): ~31.4% increase (from Rs. Key results statement takeaways from Balaji Phosphates Ltd's Q2 FY27 results state